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A VERY RARE CAUSE OF INFANTILE SPASMS
UMA CAUSA MUITO RARA DE ESPASMOS INFANTIS
ABSTRACT
Psychomotor development regression or delay associated with epilepsy represent a diagnostic challenge. The diagnostic approach should 
take into account age group, epileptic syndrome, physical and neurological data, and organ and/or system involvement. Herein is reported the 
case of a toddler for whom hair development, epileptic seizure evolution, and electroencephalographic findings were key for Menkes kinky 
hair disease diagnosis. The typical electroclinical evolution in this syndrome has rarely been previously reported.
A 22-month-old boy, born at 35 weeks, was admitted to the hospital by the age of two months due to epileptic seizures. Physical examination 
revealed dysmorphic facial features, pectus excavatum, and inguinal hernias. Antiepileptic drugs were initiated and one month later the patient 
was readmitted with recurrent epileptic seizures. Transfer to a hospital with Pediatric Neurology support was required, where light-toned and 
pleated skin, sparse hair, failure to thrive, and axial hypotonia were remarked. Initial investigation with general metabolic, neuroimaging, 
ophthalmological, and microarray study revealed no changes. Electroencephalograms were markedly abnormal, initially with focal changes 
and later with hypsarrhythmia. Considering the patient’s phenotype, copper serum level was analysed, with null value. Molecular study 
confirmed Menkes kinky hair disease and copper histidine therapy was initiated. 
Menkes kinky hair disease should be considered in infants with global developmental delay, severe hypotonia, refractory epilepsy, and 
typical hair and skin changes occurring early in life. However, neonatal diagnosis is hampered by age-unspecific signs and symptoms.  Despite 
being a rare and fatal entity, timely diagnosis allowing early therapy institution and avoiding unnecessary additional tests and prompt genetic 
counseling are of utmost importance.
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RESUMO
A regressão ou atraso do desenvolvimento psicomotor associados a epilepsia constituem um desafio diagnóstico. A abordagem diagnóstica 
deve considerar o grupo etário, a síndrome epilética, o exame físico e neurológico e o envolvimento de órgãos/sistemas. É aqui descrito o caso 
clínico de uma criança em que o aspeto do cabelo e a evolução das crises epiléticas e dos resultados eletroencefalográficos foram importantes 
para o diagnóstico de Doença de Menkes. A evolução eletroclínica típica desta síndrome foi raramente descrita noutras publicações.
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INTRODUCTION
Epileptic encephalopathies occur at Pediatric age and have a 
wide variety of etiologies and age-dependent specificities. When 
associated with developmental delay or regression, dysmorphisms, 
or other atypical findings on physical examination, diagnosis of 
inherited metabolism disorders and/or genetic syndromes should be 
considered.1 In neurometabolic disorders, epilepsy usually occurs at 
young ages (neonates or infants).1,2  Whenever typical or identifiable 
signs are present, they should guide clinical diagnosis.1-13
Herein is described the case of a patient for whom hair 
development was the key clue for Menkes kinky hair disease (MKHD) 
diagnosis, highlighting the importance of clinical features and 
electroencephalographic findings for establishing diagnosis.
Few reports are available in the literature reporting both typical 
phenotypic features and electrophysiological findings associated 
with MKHD.
CLINICAL CASE
Herein is presented the case of a 22-month-old boy admitted to 
a tertiary hospital with initial epileptic seizures at the age of two 
months. 
Parents were apparently healthy and motor neuron disease was 
suspected in a second-degree relative (grandfather). Pregnancy and 
delivery were unremarkable, except for premature childbirth. The 
child was born at 35 weeks of gestation, with no need for resuscitation 
support. Fenton preterm growth chart percentiles were compatible 
with a small-for-gestational-age baby and he was admitted to the 
Neonatal Intensive Care Unit for 14 days, with no intercurrences. 
Physical examination revealed a particular triangular-shaped face, 
raised nostrils, prominent ears, and pectus excavatum. Lax skin and 
cephalohematoma were additionally registered.  
On first hospital admission, the boy presented with focal left 
hemiclonic seizures. Epileptic seizures were observed and focal 
epileptiform activity was evident on electroencephalogram (EEG; 
Fig.1). Treatment with sodium valproate (VPA) and phenobarbital 
(PB) was initiated and the patient was seizure-free on hospital 
discharge. Bilateral inguinal hernias and left cryptorchidism were 
detected on physical examination.
Um rapaz de 22 meses, com 35 semanas de idade gestacional, foi admitido no hospital aos dois meses de idade devido a crises epiléticas. 
O exame físico revelou fácies dismórfico, pectus excavatum e hérnias inguinais. Foram iniciados antiepiléticos e um mês depois o rapaz foi 
readmitido por crises epiléticas recorrentes. O doente foi transferido para um hospital com apoio de Neurologia Pediátrica, onde se destacaram 
a pele clara e pregueada, cabelo escasso, má evolução ponderal e hipotonia axial. A investigação inicial através de estudo metabólico geral, 
neuroimagiológico, oftalmológico e de microarray não revelou alterações. Os eletroencefalogramas encontravam-se marcadamente anormais, 
inicialmente com alterações focais e posteriormente com hipsarritmia. Atendendo ao fenótipo do doente, foi efetuado o doseamento de 
cobre, com valor nulo. O estudo molecular confirmou o diagnóstico de Doença de Menkes e foi iniciada terapêutica com histidinato de cobre.
A Doença de Menkes deve ser considerada em lactentes com atraso global do desenvolvimento, hipotonia severa, epilepsia refratária e 
alterações típicas do cabelo e pele com instalação precoce, mas é de diagnóstico neonatal difícil devido a sinais e sintomas inespecíficos nesta 
idade. Apesar de ser uma entidade rara e fatal, o diagnóstico precoce para rápida instituição terapêutica, evicção de exames complementares 
desnecessários e aconselhamento genético atempado são de extrema importância.
A perda auditiva associada à displasia do canal semicircular é mais provável devido ao desenvolvimento anômalo do labirinto membranoso, 
que não é detetável radiologicamente pela tomografia computadorizada.
Palavras-chave: aconselhamento genético; alterações do desenvolvimento; cabelo; diagnóstico precoce; doença de Menkes; doença do 
transporte de cobre; eletroencefalografia; epilepsia; manifestações neurológicas
Figure 1 (a-d) - EEG at the age of two months. Sensitivity 15 µV/mm. Runs of sharp 
waves followed by delta waves and sharp and slow wave complexes, ending with 
spikes and sharp waves on fronto-central and temporal areas, without clinical 
manifestations, corresponding to an electroencephalographic (silent) focal seizure.
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By the age of three and a half months, the boy was hospital 
readmitted with seizure recurrence and immediately transferred to 
a central hospital with Pediatric Neurology. VPA was withdrawn and 
switched to levetiracetam (LEV) in combination with previous PB, 
with clinical benefit. Thiamine supplementation was also started. 
Failure to thrive and global developmental delay were evident. 
On examination, dolichocephaly was noticed, together with axial 
hypotonia with brisk deep tendon reflex.  Light-toned and pleated 
skin and steely and sparse hair were also observed.
Initial workup performed at the age of two months − infectious 
screening through institutional protocols; serum hematological 
and biochemical study, including specific metabolic study (lactate/
pyruvate, uric acid, creatine kinase, cholesterol,  total homocysteine, 
transferrin isoelectric focusing for carbohydrate-deficient 
glycoproteins, very long chain fatty acids, serum amino acids and 
urine organic acids); microarray  study; brain magnetic resonance 
imaging (MRI); and ophthalmological evaluation  − showed no 
changes. Attending to the patient’s phenotypic characteristics, 
metabolic study was complemented with copper and ceruplasmin 
quantification on second hospital admission, at the age of three and a 
half months. Serum values were 0 μmol/L and 0.070g/L, respectively. 
Molecular study for ATP7A gene was also conducted, disclosing 
ATP7A gene mutation c. 1639C>t (P.(ARG547*) and confirming MKHD 
diagnosis. Therapy with subcutaneous copper histidine (500 μg per 
day) was started, as well as regular follow-up in Pediatric Neurology 
and Metabolic Diseases outpatient clinic. After six months of therapy, 
copper and ceruplasmin levels were 9.27 μmol/L and 0.114 g/L, 
respectively.  During this period, the patient was submitted to surgical 
repair of inguinal hernias, stopped thiamine supplementation, and 
maintained PB and LEV as antiepileptic drugs. 
By the age of 10-11 months, the boy developed clusters of epileptic 
spasms. In EEG, disorganized tracing with multifocal high voltage 
sharp and slow wave abnormalities were evident, consistent with 
hypsarrhythmia (Fig. 2a), and epileptic spasms were recorded (Fig. 
2b).  Vigabatrin (VGB) was started, with epileptic spasm reduction 
but not complete remission, and LEV was withdrawn.
At 16 months of age, EEG showed multifocal epileptiform activity 
with burst-suppression pattern during sleep (Fig. 3) and rough hair 
with alopecia areas and other particular facial features were evident 
(Fig. 3c).
From initial follow-up until present, global developmental delay was 
remarkable, with poor visual contact and language regression (only 
guttural sounds), severe global hypotonia, and no postural control 
(the boy does not sit and has no head control). Global growth has 
been persistently below percentile 3 of World Health Organization 
Child Growth Standards. The patient has been on a soft adapted age 
diet, with caloric and nutritional supplementation (medium-chain 
triacylglycerols and maltodextrin complex carbohydrate). Currently, 
at 22 months, epilepsy became refractory, with recurrent epileptic 
spasms and tonic seizures despite antiepileptic drugs.
Maternal molecular study showed the same pathogenic gene variant. 
Figure 2 - EEG at the age of 10 months. a: Sensitivity 7 µV/mm. 
Completely disorganized tracing, with no physiological elements 
and multifocal spikes and waves (hypsarrhythmia). b: Sensitivity 10 
µV/mm. High-amplitude generalized slow waves followed by some 
tracing attenuation. Trapezoid form (circle line) on muscle derivations 
(both deltoid muscles, at the bottom).
Figure 3 - EEG at the age of 16 months and facial phenotypical 
features. Sensitivity 15 µV/mm a. Sequences of generalized rhythmic 
sharp waves or spikes and slow waves (sleep). b.  Bursts of sharp 
waves and spikes and slow waves, generalized and synchronous, with 
electrical sign interposed suppression (suppression-burst pattern). c. 
Rough hair with alopecia areas, prominent ears, pudgy cheeks, back 
neck loose skin, frontal bossing, and micrognathia.
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DISCUSSION/CONCLUSIONS
 
MKHD diagnosis should be considered in infants with severe 
developmental delay, early-onset epilepsy (hemiclonic seizures or 
spasms), and peculiar hair appearance, as observed in the present 
patient. This rare disease entity has a 1/250,000 incidence and 
X-linked inheritance.3 It primarily affects males (1/140,000 male 
births), while females are usually unaffected carriers.3-7 The condition 
is characterized by generalized copper deficiency caused by mutations 
in ATP7A gene, which encodes a copper transport polypeptide-type 
ATPase that becomes defective.5,6,8 Besides MKHD most prevalent 
severe form, 9-15% of patients may have milder disease subtypes, 
such as ATP7A-related distal motor neuropathy (DMN) and occipital 
horn syndrome (OHS; the less severe form).1,3 
The ATP7A protein is found throughout the body, except in liver 
cells.9 Copper uptake in the gastrointestinal tract and copper delivery 
to the brain are compromised, resulting in low copper blood levels 
and dysfunction of several copper-dependent enzymes. This causes 
elevated plasma lactate due to complex IV deficiency (cytochrome c 
oxidase), collagen crosslinking  alteration (catalyzed by lysyl oxidase), 
and melanin production (tyrosinase), resulting in hair and skin 
abnormalities (pili torti, trichorrhexis nodosa, moniletrix, alopecia, 
light-toned hair and skin), vascular abnormalities (elongated 
vessels, tortuosity of intracranial vessels and subdural hematoma), 
and Purkinje cell degeneration in the cerebellum, as well as 
episodic hypothermia.1,3,4,6,9,10,13 Brain dopamine beta hydroxylase 
deficiency accounts for such pronounced neurological involvement.3 
Neurological symptoms, like epileptic seizures and hypotonia, 
become evident at the second or third months of life as a result of 
cerebral neurodegeneration associated with such deficit.3,13
Due to unspecific early clinical signs – prematurity, large 
cephalohematomas, and skin laxicity −, neonatal diagnosis is 
challenging.3 All these features were present in this patient. Typical 
dermatological and neurological manifestations and developmental 
delay become evident later, as also observed in the present patient.
The typical sparse, steely, and brittle hair can appear at birth or be 
the first MKHD sign at the age of one/two months.1,3,4,6 In the present 
patient, hair distinctiveness  was observed at the age of 3.5 months 
and was the main diagnostic clue, prompting further study.
Copper deficiency also implicates other body structures, like 
bone, and can manifest by osteoporosis, deformities, fractures, and 
exostosis.3,10
Failure to thrive, feeding difficulties, vomiting, and diarrhea 
represent additional MKHD symptoms. An odd appearance, frontal 
or occipital bossing, micrognathia, pudgy cheeks, pectus excavatum, 
and umbilical/inguinal hernias may also be observed.3,6 This patient 
exhibited most of these clinical features (Fig. 3c).
MKHD differential diagnosis includes Ehlers-Danlos syndrome, 
Marfan syndrome, cutis laxa, mitochondrial disorders, osteogenesis 
imperfecta, and child abuse.6,10
Initial diagnosis is based on clinical features (particularly 
typical hair changes) and supported by reduced levels of serum 
copper and ceruloplasmin. However, serum study alone in males 
under six months is problematic, given the normally low copper 
concentrations in infants this young.4  Definitive diagnosis is based 
on molecular genetic testing.4,6 A typical course of epilepsy has been 
reported in the literature, comprising an early stage with focal clonic 
seizures, often evolving into status epilepticus (at three months); an 
intermediate stage with epileptic spasms (at 6-11 months); and a late 
stage with multifocal seizures, tonic spasms, and myoclonus (at 20-25 
months).12 This pattern was also observed in this patient, except that 
early epileptic seizures were not very frequent and status epilepticus 
was not observed. 
Typical MRI may present with bilateral subdural hygromas, brain and 
cerebellar atrophy, white matter changes, and tortuous intracranial 
vessels.14,15 In the present case, MRI at the age of two months was 
normal and provided no diagnostic clue.
Overall, this patient fulfilled all MKHD diagnostic criteria: clinical 
features, EEG pattern, serum biomarkers, and molecular identification 
of ATP7A gene mutation.
Genetic counseling is extremely relevant in this context, as MKHD 
has an X-linked recessive inheritance. Approximately one third of 
affected males has no family history of MKHD/OHS/DMN. However, 
if the mother is heterozygous there is a 50% risk of transmitting 
ATP7A pathogenic variant in each pregnancy.4 In this study, maternal 
molecular study showed the same pathogenic variant.
In the most prevalent and severe MKHD form, the vast majority of 
patients dies before the age of three years, usually from infections 
or vascular complications.3 Early copper histidine treatment start 
within the first postnatal weeks extends survival beyond the age of 
three. Medical care including feeding techniques can also potentially 
improve the very poor MKHD prognosis.3,7 In this case, besides 
adapted diet and caloric supplementation, the patient did not require 
further feeding support. 
MKHD requires early diagnosis for prompt treatment start and 
multidisciplinary medical and nutritional surveillance to enable the 
most extended and quality lifetime. Additionally, timely diagnosis 
is key to avoid redundant studies and encourage adequate genetic 
counseling.
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